Caelus Life Sciences Holding Overview
- Year Founded
-
2014
- Status
-
Private
- Employees
-
5
- Latest Deal Type
-
Later Stage VC
- (Cancelled)
- Latest Deal Amount
-
$30M
- Investors
-
3
Caelus Life Sciences Holding General Information
Description
Developer of microbiome-based therapeutics designed to be used for early intervention in cardiometabolic disorders. The company's therapeutics include single-strain products that target pre-diabetes, increase the sensitivity for insulin and aim to delay the onset of diabetes in people who are overweight and have an increased risk for cardiovascular disorders, enabling patients to have a range of microbiota-based products as therapy in diabetes and late-stage cancer.
Contact Information
Website
caeluslifesciences.comCorporate Office
- PO Box 302
- 1850 AH Heiloo
- Netherlands
Corporate Office
- PO Box 302
- 1850 AH Heiloo
- Netherlands
Caelus Life Sciences Holding Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 7. Later Stage VC | $30M | Cancelled | Generating Revenue | |||
| 6. Secondary Transaction - Private | Completed | Clinical Trials - Phase 2 | ||||
| 5. Later Stage VC | 01-Dec-2022 | Completed | Clinical Trials - Phase 2 | |||
| 4. Later Stage VC | 30-Nov-2019 | Completed | Pre-Clinical Trials | |||
| 3. Early Stage VC (Series A) | 26-Jan-2017 | Completed | Pre-Clinical Trials | |||
| 2. Debt - General | $2.03M | $3.4M | Completed | Startup | ||
| 1. Early Stage VC | 01-Jan-2014 | $1.37M | $1.37M | Completed | Startup |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Caelus Life Sciences Holding Comparisons
Industry
Financing
Details
Caelus Life Sciences Holding Competitors (17)
One of Caelus Life Sciences Holding’s 17 competitors is XyloCor Therapeutics, a Venture Capital-Backed company based in King of Prussia, PA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| XyloCor Therapeutics | Venture Capital-Backed | King of Prussia, PA | ||||
| Renova Therapeutics | Venture Capital-Backed | Carlsbad, CA | ||||
| Voyager Therapeutics | Formerly VC-backed | Lexington, MA | ||||
| Lexeo Therapeutics | Formerly VC-backed | New York, NY | ||||
| Cytokinetics | Formerly VC-backed | South San Francisco, CA |
Caelus Life Sciences Holding Patents
Caelus Life Sciences Holding Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2023099579-A1 | Prevention or treatment of hepatic steatosis | Inactive | 03-Dec-2021 | ||
| WO-2022248588-A1 | Insulin-sensitizing agent and butyrate-producing bacterium | Inactive | 28-May-2021 | ||
| WO-2022063980-A1 | Fecal matter for preventing or treating intestinal microbiome aberrations in cesarean section born infants | Inactive | 25-Sep-2020 | ||
| JP-2022031800-A | Compositions and methods for preventing and / or treating vitamin b12 deficiency | Active | 25-Feb-2016 | ||
| AU-2017222990-A1 | Compositions and methods for preventing and/or treating vitamin b12 deficiency | Inactive | 25-Feb-2016 | A61K35/74 |
Caelus Life Sciences Holding Signals
Caelus Life Sciences Holding Investors (3)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Amsterdam UMC Ventures Holding | Venture Capital | Minority | ||
| UvA Ventures Holding | Venture Capital | Minority | ||
| Johnson & Johnson JJDC | Corporate Venture Capital | Minority |
Caelus Life Sciences Holding FAQs
-
When was Caelus Life Sciences Holding founded?
Caelus Life Sciences Holding was founded in 2014.
-
Where is Caelus Life Sciences Holding headquartered?
Caelus Life Sciences Holding is headquartered in Heiloo, Netherlands.
-
What is the size of Caelus Life Sciences Holding?
Caelus Life Sciences Holding has 5 total employees.
-
What industry is Caelus Life Sciences Holding in?
Caelus Life Sciences Holding’s primary industry is Drug Discovery.
-
Is Caelus Life Sciences Holding a private or public company?
Caelus Life Sciences Holding is a Private company.
-
What is the current valuation of Caelus Life Sciences Holding?
The current valuation of Caelus Life Sciences Holding is .
-
What is Caelus Life Sciences Holding’s current revenue?
The current revenue for Caelus Life Sciences Holding is .
-
How much funding has Caelus Life Sciences Holding raised over time?
Caelus Life Sciences Holding has raised $6.93M.
-
Who are Caelus Life Sciences Holding’s investors?
Amsterdam UMC Ventures Holding, UvA Ventures Holding, and Johnson & Johnson JJDC have invested in Caelus Life Sciences Holding.
-
Who are Caelus Life Sciences Holding’s competitors?
XyloCor Therapeutics, Renova Therapeutics, Voyager Therapeutics, Lexeo Therapeutics, and Cytokinetics are some of the 17 competitors of Caelus Life Sciences Holding.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process